ANTI-CANCER DRUGS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2111257, encodeId=528c211125ebe, content=图片能成功上传，但生成的PDF中不能显示咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:18:52 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=571849, encodeId=368d5e1849d2, content=这个杂志现在到底有多慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Tue Jun 04 08:51:00 CST 2019, time=2019-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090052, encodeId=1ac22090052db, content= 两天就接受了，请问一下大家如果想非OA的话要给编辑写信呢还是啥都不管了？还有非OA的版面费多少啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e35737223, createdName=ms9000000457857047, createdTime=Sat Sep 24 02:04:16 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106995, encodeId=f77a210699521, content=来了proof回答和解决文章的格式问题！重点系统里找不到上传proof的地方！！只能邮件连带pdf回过去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1d85494420, createdName=凌宝宝, createdTime=Wed Dec 21 21:30:08 CST 2022, time=2022-12-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1225124, encodeId=84321225124c0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;药物 经验分享：接受很快，但迟迟没有出proof,邮件联系不回复，各位有没有同样情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cd622441708, createdName=123d7a75m52暂无昵称, createdTime=Wed Jun 08 07:31:24 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977040, encodeId=6ec99e7040b7, content=投稿第二天状态就变成了Accept pending Major Revisions，给了三条修改意见，这是改完接受的意思吗？都没送外审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6ea5471025, createdName=ms8000000417579314, createdTime=Sat Jun 26 11:24:53 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586487, encodeId=d08c58648ebe, content=这个杂志快的话两三个月接受（good manuscript），慢的话要5-9个月，paper格式改的让人有点抓狂，而且已经发表的文章让人有点嫌弃，很多都是黑白图，而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:15:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100806, encodeId=b13621008068f, content=秒拒，被转投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ece8281039, createdName=ms7000001240228146, createdTime=Wed Nov 16 08:52:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114143, encodeId=b3422114143f6, content=偏重的研究方向：肿瘤;药物 经验分享：秒拒体验感不错起码不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1ab6515335, createdName=ms3000000414692858, createdTime=Sat Feb 11 18:45:50 CST 2023, time=2023-02-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111254, encodeId=de6321112546f, content=请问图片可以成功上传，但生成的PDF里不能显示图片咋办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:12:21 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省)]

2023-01-23 121c7201m56(暂无昵称) 来自河南省

图片能成功上传，但生成的PDF中不能显示咋回事

152 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111257, encodeId=528c211125ebe, content=图片能成功上传，但生成的PDF中不能显示咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:18:52 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=571849, encodeId=368d5e1849d2, content=这个杂志现在到底有多慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Tue Jun 04 08:51:00 CST 2019, time=2019-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090052, encodeId=1ac22090052db, content= 两天就接受了，请问一下大家如果想非OA的话要给编辑写信呢还是啥都不管了？还有非OA的版面费多少啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e35737223, createdName=ms9000000457857047, createdTime=Sat Sep 24 02:04:16 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106995, encodeId=f77a210699521, content=来了proof回答和解决文章的格式问题！重点系统里找不到上传proof的地方！！只能邮件连带pdf回过去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1d85494420, createdName=凌宝宝, createdTime=Wed Dec 21 21:30:08 CST 2022, time=2022-12-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1225124, encodeId=84321225124c0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;药物 经验分享：接受很快，但迟迟没有出proof,邮件联系不回复，各位有没有同样情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cd622441708, createdName=123d7a75m52暂无昵称, createdTime=Wed Jun 08 07:31:24 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977040, encodeId=6ec99e7040b7, content=投稿第二天状态就变成了Accept pending Major Revisions，给了三条修改意见，这是改完接受的意思吗？都没送外审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6ea5471025, createdName=ms8000000417579314, createdTime=Sat Jun 26 11:24:53 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586487, encodeId=d08c58648ebe, content=这个杂志快的话两三个月接受（good manuscript），慢的话要5-9个月，paper格式改的让人有点抓狂，而且已经发表的文章让人有点嫌弃，很多都是黑白图，而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:15:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100806, encodeId=b13621008068f, content=秒拒，被转投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ece8281039, createdName=ms7000001240228146, createdTime=Wed Nov 16 08:52:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114143, encodeId=b3422114143f6, content=偏重的研究方向：肿瘤;药物 经验分享：秒拒体验感不错起码不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1ab6515335, createdName=ms3000000414692858, createdTime=Sat Feb 11 18:45:50 CST 2023, time=2023-02-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111254, encodeId=de6321112546f, content=请问图片可以成功上传，但生成的PDF里不能显示图片咋办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:12:21 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省)]

2019-06-04 1e0e201bm72(暂无匿称)

这个杂志现在到底有多慢啊

196 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111257, encodeId=528c211125ebe, content=图片能成功上传，但生成的PDF中不能显示咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:18:52 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=571849, encodeId=368d5e1849d2, content=这个杂志现在到底有多慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Tue Jun 04 08:51:00 CST 2019, time=2019-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090052, encodeId=1ac22090052db, content= 两天就接受了，请问一下大家如果想非OA的话要给编辑写信呢还是啥都不管了？还有非OA的版面费多少啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e35737223, createdName=ms9000000457857047, createdTime=Sat Sep 24 02:04:16 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106995, encodeId=f77a210699521, content=来了proof回答和解决文章的格式问题！重点系统里找不到上传proof的地方！！只能邮件连带pdf回过去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1d85494420, createdName=凌宝宝, createdTime=Wed Dec 21 21:30:08 CST 2022, time=2022-12-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1225124, encodeId=84321225124c0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;药物 经验分享：接受很快，但迟迟没有出proof,邮件联系不回复，各位有没有同样情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cd622441708, createdName=123d7a75m52暂无昵称, createdTime=Wed Jun 08 07:31:24 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977040, encodeId=6ec99e7040b7, content=投稿第二天状态就变成了Accept pending Major Revisions，给了三条修改意见，这是改完接受的意思吗？都没送外审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6ea5471025, createdName=ms8000000417579314, createdTime=Sat Jun 26 11:24:53 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586487, encodeId=d08c58648ebe, content=这个杂志快的话两三个月接受（good manuscript），慢的话要5-9个月，paper格式改的让人有点抓狂，而且已经发表的文章让人有点嫌弃，很多都是黑白图，而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:15:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100806, encodeId=b13621008068f, content=秒拒，被转投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ece8281039, createdName=ms7000001240228146, createdTime=Wed Nov 16 08:52:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114143, encodeId=b3422114143f6, content=偏重的研究方向：肿瘤;药物 经验分享：秒拒体验感不错起码不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1ab6515335, createdName=ms3000000414692858, createdTime=Sat Feb 11 18:45:50 CST 2023, time=2023-02-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111254, encodeId=de6321112546f, content=请问图片可以成功上传，但生成的PDF里不能显示图片咋办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:12:21 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省)]

2022-09-24 ms9000000457857047

两天就接受了，请问一下大家如果想非OA的话要给编辑写信呢还是啥都不管了？还有非OA的版面费多少啊？

243 12 举报

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111257, encodeId=528c211125ebe, content=图片能成功上传，但生成的PDF中不能显示咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:18:52 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=571849, encodeId=368d5e1849d2, content=这个杂志现在到底有多慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Tue Jun 04 08:51:00 CST 2019, time=2019-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090052, encodeId=1ac22090052db, content= 两天就接受了，请问一下大家如果想非OA的话要给编辑写信呢还是啥都不管了？还有非OA的版面费多少啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e35737223, createdName=ms9000000457857047, createdTime=Sat Sep 24 02:04:16 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106995, encodeId=f77a210699521, content=来了proof回答和解决文章的格式问题！重点系统里找不到上传proof的地方！！只能邮件连带pdf回过去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1d85494420, createdName=凌宝宝, createdTime=Wed Dec 21 21:30:08 CST 2022, time=2022-12-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1225124, encodeId=84321225124c0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;药物 经验分享：接受很快，但迟迟没有出proof,邮件联系不回复，各位有没有同样情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cd622441708, createdName=123d7a75m52暂无昵称, createdTime=Wed Jun 08 07:31:24 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977040, encodeId=6ec99e7040b7, content=投稿第二天状态就变成了Accept pending Major Revisions，给了三条修改意见，这是改完接受的意思吗？都没送外审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6ea5471025, createdName=ms8000000417579314, createdTime=Sat Jun 26 11:24:53 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586487, encodeId=d08c58648ebe, content=这个杂志快的话两三个月接受（good manuscript），慢的话要5-9个月，paper格式改的让人有点抓狂，而且已经发表的文章让人有点嫌弃，很多都是黑白图，而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:15:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100806, encodeId=b13621008068f, content=秒拒，被转投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ece8281039, createdName=ms7000001240228146, createdTime=Wed Nov 16 08:52:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114143, encodeId=b3422114143f6, content=偏重的研究方向：肿瘤;药物 经验分享：秒拒体验感不错起码不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1ab6515335, createdName=ms3000000414692858, createdTime=Sat Feb 11 18:45:50 CST 2023, time=2023-02-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111254, encodeId=de6321112546f, content=请问图片可以成功上传，但生成的PDF里不能显示图片咋办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:12:21 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省)]

2022-12-21 凌宝宝来自江苏省

来了proof回答和解决文章的格式问题！重点系统里找不到上传proof的地方！！只能邮件连带pdf回过去。。。

153 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111257, encodeId=528c211125ebe, content=图片能成功上传，但生成的PDF中不能显示咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:18:52 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=571849, encodeId=368d5e1849d2, content=这个杂志现在到底有多慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Tue Jun 04 08:51:00 CST 2019, time=2019-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090052, encodeId=1ac22090052db, content= 两天就接受了，请问一下大家如果想非OA的话要给编辑写信呢还是啥都不管了？还有非OA的版面费多少啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e35737223, createdName=ms9000000457857047, createdTime=Sat Sep 24 02:04:16 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106995, encodeId=f77a210699521, content=来了proof回答和解决文章的格式问题！重点系统里找不到上传proof的地方！！只能邮件连带pdf回过去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1d85494420, createdName=凌宝宝, createdTime=Wed Dec 21 21:30:08 CST 2022, time=2022-12-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1225124, encodeId=84321225124c0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;药物 经验分享：接受很快，但迟迟没有出proof,邮件联系不回复，各位有没有同样情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cd622441708, createdName=123d7a75m52暂无昵称, createdTime=Wed Jun 08 07:31:24 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977040, encodeId=6ec99e7040b7, content=投稿第二天状态就变成了Accept pending Major Revisions，给了三条修改意见，这是改完接受的意思吗？都没送外审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6ea5471025, createdName=ms8000000417579314, createdTime=Sat Jun 26 11:24:53 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586487, encodeId=d08c58648ebe, content=这个杂志快的话两三个月接受（good manuscript），慢的话要5-9个月，paper格式改的让人有点抓狂，而且已经发表的文章让人有点嫌弃，很多都是黑白图，而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:15:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100806, encodeId=b13621008068f, content=秒拒，被转投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ece8281039, createdName=ms7000001240228146, createdTime=Wed Nov 16 08:52:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114143, encodeId=b3422114143f6, content=偏重的研究方向：肿瘤;药物 经验分享：秒拒体验感不错起码不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1ab6515335, createdName=ms3000000414692858, createdTime=Sat Feb 11 18:45:50 CST 2023, time=2023-02-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111254, encodeId=de6321112546f, content=请问图片可以成功上传，但生成的PDF里不能显示图片咋办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:12:21 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省)]

2022-06-08 123d7a75m52暂无昵称

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤;药物
经验分享：接受很快，但迟迟没有出proof,邮件联系不回复，各位有没有同样情况？

148 10 举报

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111257, encodeId=528c211125ebe, content=图片能成功上传，但生成的PDF中不能显示咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:18:52 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=571849, encodeId=368d5e1849d2, content=这个杂志现在到底有多慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Tue Jun 04 08:51:00 CST 2019, time=2019-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090052, encodeId=1ac22090052db, content= 两天就接受了，请问一下大家如果想非OA的话要给编辑写信呢还是啥都不管了？还有非OA的版面费多少啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e35737223, createdName=ms9000000457857047, createdTime=Sat Sep 24 02:04:16 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106995, encodeId=f77a210699521, content=来了proof回答和解决文章的格式问题！重点系统里找不到上传proof的地方！！只能邮件连带pdf回过去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1d85494420, createdName=凌宝宝, createdTime=Wed Dec 21 21:30:08 CST 2022, time=2022-12-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1225124, encodeId=84321225124c0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;药物 经验分享：接受很快，但迟迟没有出proof,邮件联系不回复，各位有没有同样情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cd622441708, createdName=123d7a75m52暂无昵称, createdTime=Wed Jun 08 07:31:24 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977040, encodeId=6ec99e7040b7, content=投稿第二天状态就变成了Accept pending Major Revisions，给了三条修改意见，这是改完接受的意思吗？都没送外审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6ea5471025, createdName=ms8000000417579314, createdTime=Sat Jun 26 11:24:53 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586487, encodeId=d08c58648ebe, content=这个杂志快的话两三个月接受（good manuscript），慢的话要5-9个月，paper格式改的让人有点抓狂，而且已经发表的文章让人有点嫌弃，很多都是黑白图，而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:15:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100806, encodeId=b13621008068f, content=秒拒，被转投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ece8281039, createdName=ms7000001240228146, createdTime=Wed Nov 16 08:52:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114143, encodeId=b3422114143f6, content=偏重的研究方向：肿瘤;药物 经验分享：秒拒体验感不错起码不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1ab6515335, createdName=ms3000000414692858, createdTime=Sat Feb 11 18:45:50 CST 2023, time=2023-02-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111254, encodeId=de6321112546f, content=请问图片可以成功上传，但生成的PDF里不能显示图片咋办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:12:21 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省)]

2021-06-26 ms8000000417579314

投稿第二天状态就变成了Accept pending Major Revisions，给了三条修改意见，这是改完接受的意思吗？都没送外审呀

171 14 举报

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111257, encodeId=528c211125ebe, content=图片能成功上传，但生成的PDF中不能显示咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:18:52 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=571849, encodeId=368d5e1849d2, content=这个杂志现在到底有多慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Tue Jun 04 08:51:00 CST 2019, time=2019-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090052, encodeId=1ac22090052db, content= 两天就接受了，请问一下大家如果想非OA的话要给编辑写信呢还是啥都不管了？还有非OA的版面费多少啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e35737223, createdName=ms9000000457857047, createdTime=Sat Sep 24 02:04:16 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106995, encodeId=f77a210699521, content=来了proof回答和解决文章的格式问题！重点系统里找不到上传proof的地方！！只能邮件连带pdf回过去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1d85494420, createdName=凌宝宝, createdTime=Wed Dec 21 21:30:08 CST 2022, time=2022-12-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1225124, encodeId=84321225124c0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;药物 经验分享：接受很快，但迟迟没有出proof,邮件联系不回复，各位有没有同样情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cd622441708, createdName=123d7a75m52暂无昵称, createdTime=Wed Jun 08 07:31:24 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977040, encodeId=6ec99e7040b7, content=投稿第二天状态就变成了Accept pending Major Revisions，给了三条修改意见，这是改完接受的意思吗？都没送外审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6ea5471025, createdName=ms8000000417579314, createdTime=Sat Jun 26 11:24:53 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586487, encodeId=d08c58648ebe, content=这个杂志快的话两三个月接受（good manuscript），慢的话要5-9个月，paper格式改的让人有点抓狂，而且已经发表的文章让人有点嫌弃，很多都是黑白图，而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:15:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100806, encodeId=b13621008068f, content=秒拒，被转投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ece8281039, createdName=ms7000001240228146, createdTime=Wed Nov 16 08:52:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114143, encodeId=b3422114143f6, content=偏重的研究方向：肿瘤;药物 经验分享：秒拒体验感不错起码不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1ab6515335, createdName=ms3000000414692858, createdTime=Sat Feb 11 18:45:50 CST 2023, time=2023-02-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111254, encodeId=de6321112546f, content=请问图片可以成功上传，但生成的PDF里不能显示图片咋办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:12:21 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省)]

2020-03-13 1483b36dm43(暂无昵称)

这个杂志快的话两三个月接受（good manuscript），慢的话要5-9个月，paper格式改的让人有点抓狂，而且已经发表的文章让人有点嫌弃，很多都是黑白图，而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流

272 13 举报

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111257, encodeId=528c211125ebe, content=图片能成功上传，但生成的PDF中不能显示咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:18:52 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=571849, encodeId=368d5e1849d2, content=这个杂志现在到底有多慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Tue Jun 04 08:51:00 CST 2019, time=2019-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090052, encodeId=1ac22090052db, content= 两天就接受了，请问一下大家如果想非OA的话要给编辑写信呢还是啥都不管了？还有非OA的版面费多少啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e35737223, createdName=ms9000000457857047, createdTime=Sat Sep 24 02:04:16 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106995, encodeId=f77a210699521, content=来了proof回答和解决文章的格式问题！重点系统里找不到上传proof的地方！！只能邮件连带pdf回过去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1d85494420, createdName=凌宝宝, createdTime=Wed Dec 21 21:30:08 CST 2022, time=2022-12-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1225124, encodeId=84321225124c0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;药物 经验分享：接受很快，但迟迟没有出proof,邮件联系不回复，各位有没有同样情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cd622441708, createdName=123d7a75m52暂无昵称, createdTime=Wed Jun 08 07:31:24 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977040, encodeId=6ec99e7040b7, content=投稿第二天状态就变成了Accept pending Major Revisions，给了三条修改意见，这是改完接受的意思吗？都没送外审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6ea5471025, createdName=ms8000000417579314, createdTime=Sat Jun 26 11:24:53 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586487, encodeId=d08c58648ebe, content=这个杂志快的话两三个月接受（good manuscript），慢的话要5-9个月，paper格式改的让人有点抓狂，而且已经发表的文章让人有点嫌弃，很多都是黑白图，而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:15:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100806, encodeId=b13621008068f, content=秒拒，被转投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ece8281039, createdName=ms7000001240228146, createdTime=Wed Nov 16 08:52:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114143, encodeId=b3422114143f6, content=偏重的研究方向：肿瘤;药物 经验分享：秒拒体验感不错起码不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1ab6515335, createdName=ms3000000414692858, createdTime=Sat Feb 11 18:45:50 CST 2023, time=2023-02-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111254, encodeId=de6321112546f, content=请问图片可以成功上传，但生成的PDF里不能显示图片咋办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:12:21 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省)]

2022-11-16 ms7000001240228146

秒拒，被转投了

240 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111257, encodeId=528c211125ebe, content=图片能成功上传，但生成的PDF中不能显示咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:18:52 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=571849, encodeId=368d5e1849d2, content=这个杂志现在到底有多慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Tue Jun 04 08:51:00 CST 2019, time=2019-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090052, encodeId=1ac22090052db, content= 两天就接受了，请问一下大家如果想非OA的话要给编辑写信呢还是啥都不管了？还有非OA的版面费多少啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e35737223, createdName=ms9000000457857047, createdTime=Sat Sep 24 02:04:16 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106995, encodeId=f77a210699521, content=来了proof回答和解决文章的格式问题！重点系统里找不到上传proof的地方！！只能邮件连带pdf回过去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1d85494420, createdName=凌宝宝, createdTime=Wed Dec 21 21:30:08 CST 2022, time=2022-12-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1225124, encodeId=84321225124c0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;药物 经验分享：接受很快，但迟迟没有出proof,邮件联系不回复，各位有没有同样情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cd622441708, createdName=123d7a75m52暂无昵称, createdTime=Wed Jun 08 07:31:24 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977040, encodeId=6ec99e7040b7, content=投稿第二天状态就变成了Accept pending Major Revisions，给了三条修改意见，这是改完接受的意思吗？都没送外审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6ea5471025, createdName=ms8000000417579314, createdTime=Sat Jun 26 11:24:53 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586487, encodeId=d08c58648ebe, content=这个杂志快的话两三个月接受（good manuscript），慢的话要5-9个月，paper格式改的让人有点抓狂，而且已经发表的文章让人有点嫌弃，很多都是黑白图，而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:15:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100806, encodeId=b13621008068f, content=秒拒，被转投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ece8281039, createdName=ms7000001240228146, createdTime=Wed Nov 16 08:52:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114143, encodeId=b3422114143f6, content=偏重的研究方向：肿瘤;药物 经验分享：秒拒体验感不错起码不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1ab6515335, createdName=ms3000000414692858, createdTime=Sat Feb 11 18:45:50 CST 2023, time=2023-02-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111254, encodeId=de6321112546f, content=请问图片可以成功上传，但生成的PDF里不能显示图片咋办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:12:21 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省)]

2023-02-11 ms3000000414692858 来自江苏省

偏重的研究方向：肿瘤;药物
经验分享：秒拒体验感不错起码不耽误事

147 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2111257, encodeId=528c211125ebe, content=图片能成功上传，但生成的PDF中不能显示咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:18:52 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=571849, encodeId=368d5e1849d2, content=这个杂志现在到底有多慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Tue Jun 04 08:51:00 CST 2019, time=2019-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090052, encodeId=1ac22090052db, content= 两天就接受了，请问一下大家如果想非OA的话要给编辑写信呢还是啥都不管了？还有非OA的版面费多少啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e35737223, createdName=ms9000000457857047, createdTime=Sat Sep 24 02:04:16 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106995, encodeId=f77a210699521, content=来了proof回答和解决文章的格式问题！重点系统里找不到上传proof的地方！！只能邮件连带pdf回过去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1d85494420, createdName=凌宝宝, createdTime=Wed Dec 21 21:30:08 CST 2022, time=2022-12-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1225124, encodeId=84321225124c0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;药物 经验分享：接受很快，但迟迟没有出proof,邮件联系不回复，各位有没有同样情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cd622441708, createdName=123d7a75m52暂无昵称, createdTime=Wed Jun 08 07:31:24 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977040, encodeId=6ec99e7040b7, content=投稿第二天状态就变成了Accept pending Major Revisions，给了三条修改意见，这是改完接受的意思吗？都没送外审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6ea5471025, createdName=ms8000000417579314, createdTime=Sat Jun 26 11:24:53 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586487, encodeId=d08c58648ebe, content=这个杂志快的话两三个月接受（good manuscript），慢的话要5-9个月，paper格式改的让人有点抓狂，而且已经发表的文章让人有点嫌弃，很多都是黑白图，而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Fri Mar 13 00:15:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100806, encodeId=b13621008068f, content=秒拒，被转投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ece8281039, createdName=ms7000001240228146, createdTime=Wed Nov 16 08:52:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114143, encodeId=b3422114143f6, content=偏重的研究方向：肿瘤;药物 经验分享：秒拒体验感不错起码不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1ab6515335, createdName=ms3000000414692858, createdTime=Sat Feb 11 18:45:50 CST 2023, time=2023-02-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111254, encodeId=de6321112546f, content=请问图片可以成功上传，但生成的PDF里不能显示图片咋办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a5a2281279, createdName=121c7201m56(暂无昵称), createdTime=Mon Jan 23 22:12:21 CST 2023, time=2023-01-23, status=1, ipAttribution=河南省)]

2023-01-23 121c7201m56(暂无昵称) 来自河南省

请问图片可以成功上传，但生成的PDF里不能显示图片咋办

149 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务